Jubilant Pharmova Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Jubilant Pharmova stock has a consensus rating of "Hold" and an average price target of ₹1,139. The average 1-year stock price forecast is 18.15% higher than the current stock price, while the lowest is ₹930.00 (-3.53%) and the highest is ₹1,348 (+39.83%).

Price Target: ₹1,139 (+18.15%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	₹930.00	₹1,139	₹1,139	₹1,348
Change	-3.53%	+18.15%	+18.15%	+39.83%

* Price targets were last updated on Feb 8, 2026.

Analyst Ratings

The average analyst rating for Jubilant Pharmova stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	2	2	2	1
Buy	0	0	0	0	0	0
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	1
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst ICICI Securities No rating	ICICI Securities	Buy Maintains ₹1,310	Buy	Maintains	₹1,310	+35.89%	Feb 8, 2026

Financial Forecast

Revenue This Year

95.33B

from 82.80B

15.14%

from 82.80B

Revenue Next Year

108.29B

from 95.33B

13.60%

from 95.33B

EPS This Year

37.30

from 27.49

35.68%

from 27.49

EPS Next Year

50.80

from 37.30

36.19%

from 37.30

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	61.30B	62.82B	67.03B	72.35B	82.80B	95.33B
Revenue Growth	0.52%	2.47%	6.71%	7.93%	14.45%	15.14%
Gross Profit	46.42B	42.00B	43.52B	46.99B	56.35B	66.45B
Gross Margin	75.73%	66.86%	64.92%	64.95%	68.06%	69.70%
Operating Income	8.40B	3.75B	5.23B	8.03B	8.19B	12.31B
Net Income	4.14B	-610.00M	771.00M	8.39B	3.99B	4.67B
EPS	-	-	-	-	27.49	37.30
EPS Growth	-	-	-	-	-18.05%	35.68%
Forward PE	-	-	-	-	-	25.84
Dividend / Share	5.00	5.00	5.00	5.00	5.00	4.45
Dividend Growth	-	-	-	-	-	-11.00%
Free Cash Flow	463.38M	-1.58B	-3.41B	2.85B	-5.68B	8.06B
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028
High	96.9B
Avg	95.3B
Low	93.7B

Revenue Growth

Revenue Growth	2027	2028
High	17.1%
Avg	15.1%
Low	13.2%

EPS Forecast

EPS	2027	2028
High	45.30
Avg	37.30
Low	29.30

EPS Growth

EPS Growth	2027	2028
High	64.8%
Avg	35.7%
Low	6.6%